Columnist: Will Soliman
Dr. William Soliman is currently Global Medical Director with Retrophin Pharmaceuticals. He is a senior executive with several years of experience in the pharmaceutical and biotechnology industry. He is also the founder of the Apotheker Group, an organization dedicated to helping MD, PharmD, and PhD professionals successfully transition into the pharmaceutical industry. Most recently, Dr. Soliman served as global medical director at Eisai. He has also held a variety of critical management roles across the industry at Gilead Sciences, Abbott Laboratories, Boehringer Ingelheim, and Merck. Dr. Soliman previously served as vice president of Medical and Scientific Affairs at CME LLC. Dr. Soliman earned his PhD, MPhil from Columbia University, his bachelor’s degree from New York University, and his master’s degree from St. Peter’s University.